Fidelity Advisor Biotechnology Fund - Class C (FBTCX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
28.86
-0.07 (-0.24%)
At close: Feb 13, 2026
FBTCX Holdings Information
FBTCX is a mutual fund with a total of 88 individual holdings. The top holdings are AbbVie stock at 17.22%, Alnylam Pharmaceuticals at 6.31%, Gilead Sciences at 5.75%, argenx SE at 4.55%, and Ascendis Pharma at 4.29%.
Total Holdings
88
Top 10 Percentage
53.99%
Asset Class
Equity
Fund Category
Health
Assets
1.87B
Forward PE Ratio
18.05
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ABBV | AbbVie Inc. | 17.22% |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 6.31% |
| 3 | GILD | Gilead Sciences, Inc. | 5.75% |
| 4 | ARGX | argenx SE | 4.55% |
| 5 | ASND | Ascendis Pharma A/S | 4.29% |
| 6 | COGT | Cogent Biosciences, Inc. | 3.98% |
| 7 | INSM | Insmed Incorporated | 3.40% |
| 8 | VRDN | Viridian Therapeutics, Inc. | 3.01% |
| 9 | BIIB | Biogen Inc. | 2.81% |
| 10 | AMGN | Amgen Inc. | 2.68% |
| 11 | NUVL | Nuvalent, Inc. | 2.25% |
| 12 | PCVX | Vaxcyte, Inc. | 2.21% |
| 13 | APGE | Apogee Therapeutics, Inc. | 1.85% |
| 14 | GPCR | Structure Therapeutics Inc. | 1.82% |
| 15 | XENE | Xenon Pharmaceuticals Inc. | 1.73% |
| 16 | DNTH | Dianthus Therapeutics, Inc. | 1.63% |
| 17 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.59% |
| 18 | CYTK | Cytokinetics, Incorporated | 1.51% |
| 19 | SRRK | Scholar Rock Holding Corporation | 1.39% |
| 20 | EBR: UCB | UCB SA | 1.39% |
| 21 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.37% |
| 22 | MRNA | Moderna, Inc. | 1.37% |
| 23 | VKTX | Viking Therapeutics, Inc. | 1.35% |
| 24 | SYRE | Spyre Therapeutics, Inc. | 1.33% |
| 25 | QURE | uniQure N.V. | 1.29% |
As of Dec 31, 2025